Optimization of repeat plerixafor dosing for autologous peripheral blood stem-cell collection
Peripheral CD34+ cells may be mobilized using filgrastim alone or in combination with chemotherapy. The addition of plerixafor can be efficacious, though guidelines for repeat dosing are lacking.
Source: Transfusion and Apheresis Science - Category: Hematology Authors: Gaurav K. Gupta, Sarah Perreault, Stuart E. Seropian, Christopher A. Tormey, Jeanne E. Hendrickson Source Type: research
More News: Chemotherapy | Filgrastim | Hematology | Neulasta | Neupogen | Science | Stem Cell Therapy | Stem Cells